[1] Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictors

[2] Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial

[3] Enteric Infections and Diarrhea in Human Immunodeficiency Virus–Infected Persons: Prospective Community-Based Cohort Study

[4] Efficacy of Risk-Reduction Counseling to Prevent Human Immunodeficiency Virus and Sexually Transmitted Diseases: A Randomized Controlled Trial

[5] seroprevalence of hiv infection among high-risk groups in kohgiloyeh and boyerahmad province in 2009

[6] high level of hbv dna virus in the breast milk seems not to contraindicate breastfeeding

[7] pregnant women who have hiv / aids in the context of vertical transmission: visibility of national scientific production in health

[8] circulating loxl2 levels reflect severity of intestinal fibrosis and galt cd4+ t lymphocyte depletion in treated hiv infection

[9] Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccine.

[10] Novel 1,5-Diphenylpyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant:  Lead Identification and SAR of 3- and 4-Substituted Derivatives

[11] Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study.

[12] What are mass media interventions made of? Exploring the active content of interventions designed to increase HIV testing in gay men within a systematic review.

[13] Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study.

[14] Feasibility of community-based HIV self-screening in South Africa: a demonstration project.

[15] Fungal Opportunistic Pneumonias in HIV/AIDS Patients: An Indian Tertiary Care Experience.

[16] Performance analysis of MySQL partition, hive partition-bucketing and Apache Pig

[17] Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.

[18] Molecular Docking Study of Four Chromene Derivatives as Novel HIV-1 Integrase Inhibitors

[19] Histoplasmosis, An Underdiagnosed Disease Affecting People Living with HIV/AIDS in Brazil: Results of a Multicenter Prospective Cohort Study Using Both Classical Mycology Tests and Histoplasma Urine Antigen Detection

[20] Recent advances in managing HIV-associated cryptococcal meningitis [version 1; peer review: 2 approved]

[21] Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

[22] The performance of serum cryptococcal capsular polysaccharide antigen test, histopathology and culture of the lung tissue for diagnosis of pulmonary cryptococosis in patients without HIV infection

[23] Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China

[24] Recurrent tuberculosis among HIV-coinfected patients: a case series from KwaZulu-Natal

[25] High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014

[26] Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS

[27] The role of dolutegravir in the management of HIV infections

[28] Long-term efficacy and safety of raltegravir in the management of HIV infection

[29] Patterns of resistance development with integrase inhibitors in HIV

[30] Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy

[31] Methicillin-resistant Staphylococcus aureus in HIV-infected patients

[32] Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection

[33] Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

[34] Factors Associated with Anemia among People Living with HIV/AIDS Taking ART in Ethiopia

[35] Knowledge, Attitude, and Practice of Postexposure Prophylaxis against HIV Infection among Healthcare Workers in Hiwot Fana Specialized University Hospital, Eastern Ethiopia

[36] Primary HIV Drug Resistance among Recently Infected Cases of HIV in North-West India

[37] Consistent Condom Use and Associated Factors among HIV-Positive Clients on Antiretroviral Therapy in North West Ethiopian Health Center, 2016 GC

[38] Healthcare Workers’ Perspectives on the Barriers to Providing HIV Services to Children in Sub-Saharan Africa

[39] Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90 of HIV-Infected Individuals

[40] The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya

[41] Cryptococcal Meningitis in a HIV Seronegative Patient: A Rare Complication of Cerebrospinal Fluid Leak Detected with a New Cisternographic Technique

[42] The performance of serum cryptococcal capsular polysaccharide antigen test, histopathology and culture of the lung tissue for diagnosis of pulmonary cryptococosis in patients without HIV infection

[43] Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China

[44] Recurrent tuberculosis among HIV-coinfected patients: a case series from KwaZulu-Natal

[45] Depression among Adult HIV/AIDS Patients Attending ART Clinics at Aksum Town, Aksum, Ethiopia: A Cross-Sectional Study

[46] High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014

[47] Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS

[48] The role of dolutegravir in the management of HIV infections

[49] Long-term efficacy and safety of raltegravir in the management of HIV infection

[50] Patterns of resistance development with integrase inhibitors in HIV

[51] Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy

[52] Methicillin-resistant Staphylococcus aureus in HIV-infected patients

[53] Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection

[54] The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa

[55] Integration of HIV-Sexual Reproductive Health Services for Young People and the Barriers at Public Health Facilities in Mbarara Municipality, Southwestern Uganda: A Qualitative Assessment

[56] Longitudinal brain atrophy patterns and neuropsychological performance in older adults with HIV-associated neurocognitive disorder compared with early Alzheimer's disease.

[57] Adverse childhood experiences, mental health, substance use, and HIV-related outcomes among persons with HIV

[58] Barriers and facilitators to participation of men who have sex with men and transgender women in HIV research in Jamaica.

[59] Tobacco Smoking, Substance Use, and Mental Health Symptoms in People with HIV in an Urban HIV Clinic.

[60] Clinical correlates of depression chronicity among people living with HIV: What is the role of suicidal ideation?

[61] The global magnitude of metabolic syndrome among antiretroviral therapy (ART) exposed and ART-naïve adult HIV-infected patients in gedio-zone, southern Ethiopia: Comparative cross-sectional study, using the Adult Treatment Panel III criteria.

[62] Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort.

[63] "This conflict has turned me into a Doctor, Nurse and Nutritionist at the same time": How peer support among HIV-positive IDPs created opportunities for care in conflict-stricken Kabaré, Congo DR

[64] Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIV-infected Persons.

[65] Gastrointestinal Parasitic Infections and Immunological Status of HIV/AIDS Coinfected Individuals in Nigeria.

[66] Teledrama and HIV/AIDS Awareness in Nigeria: A Critique of Zuciyar Zinariya, on TV Taraba

[67] Structural and binding insights into HIV-1 protease and P2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis.

[68] [Factors related to oral candidiasis in HIV children and adolescents, species characterization and antifungal susceptibility].

[69] On the periphery of HIV and AIDS: Reflections on stress as experienced by caregivers in a child residential care facility in South Africa.

[70] Knowledge, attitudes, and practices regarding antiretroviral management, reproductive health, sexually transmitted infections, and sexual risk behavior among perinatally HIV-infected youth in Thailand.

[71] Factors influencing uptake of HIV care and treatment among children in South Africa - a qualitative study of caregivers and clinic staff.

[72] A case of historical adaptation in Iranian media: Shahrzad as a palimpsestuous hive of intertextuality

[73] The global spread of HIV-1 subtype B epidemic.

[74] Travel, migration and HIV.

[75] Verifying the impact of corporate governance on hospital performance on HIV and malaria control: A structural equation modelling approach.

[76] Malaria care-seeking behaviour among HIV-infected patients receiving antiretroviral treatment in South-Eastern Nigeria: A cross-sectional study.

[77] Prevalence of malaria parasitaemia in adult HIV-infected patients in Jos, North-central Nigeria.

[78] HIV–malaria coinfection: Anti-malaria therapy in people living with HIV/AIDS in Owerri, Nigeria

[79] Acceptability of HIV self-testing in African students: a cross-sectional survey in the Democratic Republic of Congo.

[80] Comorbidity and polypharmacy among women living with HIV in British Columbia.

[81] Avaliação da autoestima em pessoas vivendo com HIV/aids no município de Ribeirão Preto-SP

[82] The effectiveness of acceptance and commitment therapy on death anxiety and mental health in women with hiv in abadan city, iran

[83] Securitizing HIV/AIDS: a game changer in state-societal relations in China?

[84] Scaling-up the Systems Analysis and Improvement Approach for prevention of mother-to-child HIV transmission in Mozambique (SAIA-SCALE): a stepped-wedge cluster randomized trial.

[85] Reducing the African American HIV Disease Burden in the Deep South: Addressing the Role of Faith and Spirituality.

[86] Cancer, chemotherapy, and HIV: Living with cancer amidst comorbidity in a South African township.

[87] Renal manifestations of HIV during the antiretroviral era in South Africa: a systematic scoping review

[88] D-dimer as a Predictor of Altered Coagulation in HIV Patients in Nigeria.

[89] Progress toward HIV epidemic control in lesotho: results from a population-based survey.

[90] Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care.

[91] Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.

[92] Multisystem impairment in South African adolescents with Perinatally acquired HIV on antiretroviral therapy (ART).

[93] Incidence and Risk Factors for Renal Disease in an Outpatient Cohort of HIV-Infected Patients on Antiretroviral Therapy.

[94] Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load

[95] Feasibility of using dried blood spots for HIV viral load testing among HIV-infected individuals in Thailand using QIAGEN QIAsymphony-artus HIV-1 platform

[96] Impact of HIV-Status Disclosure on HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy

[97] Evaluating the effectiveness of the HIV adolescent package of care (APOC) training on viral load suppression in Kenya

[98] HIV stigma and viral load among African-American women receiving treatment for HIV

[99] Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults with Incident HIV-1 Infection

[100] Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study)

[101] Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study